| Mr David J Debono, MD | |
|
1901 Star Batt Dr, Suite 200, Rochester Hills, MI 48309-3712 | |
| (248) 844-5690 | |
| (248) 844-5691 |
| Full Name | Mr David J Debono |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1901 Star Batt Dr, Rochester Hills, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588688840 | NPI | - | NPPES |
| 036093118 | Medicaid | IL |
| Mailing Address | Practice Location Address |
|---|---|
| Mr David J Debono, MD 1901 Star Batt Dr, Suite 200, Rochester Hills, MI 48309-3712 Ph: (248) 844-5690 | Mr David J Debono, MD 1901 Star Batt Dr, Suite 200, Rochester Hills, MI 48309-3712 Ph: (248) 844-5690 |
News Archive
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension on December 7, 2012.
A researcher at The University of Texas at Arlington has teamed up with a colleague at UT Southwestern Medical Center on a biopsy image analysis that will help pinpoint care for lung cancer patients.
A new study from American Cancer Society researchers finds it's not just how much physical activity you get, but how much time you spend sitting that can affect your risk of death. Researchers say time spent sitting was independently associated with total mortality, regardless of physical activity level. They conclude that public health messages should promote both being physically active and reducing time spent sitting. The study appears early online in the American Journal of Epidemiology.
Edison Pharmaceuticals today announced that the US Food and Drug Administration has granted Orphan Status to vatiquinone for the treatment of Friedreich's ataxia.
› Verified 4 days ago
Dr. Mara L Geiger, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E, Ste 290, Rochester Hills, MI 48307 Phone: 248-997-7900 Fax: 248-997-7918 | |
Andrew Dean Scrogin, M. D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1854 W Auburn Rd Ste 100a, Rochester Hills, MI 48309 Phone: 248-696-3170 Fax: 248-696-3175 | |
Dr. Cordell L Yoder, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd East, Ste 250, Rochester Hills, MI 48307 Phone: 248-293-1002 Fax: 248-293-1272 | |
Lauren Pomorski, PA-C Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1460 Walton Blvd Ste 200, Rochester Hills, MI 48309 Phone: 248-650-1800 Fax: 248-650-1856 | |
Brittany Derra, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 South Boulevard E, Suite 290, Rochester Hills, MI 48307 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Freeha Khan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E Ste 300, Rochester Hills, MI 48307 Phone: 248-844-9710 | |
Dr. Todd M Hachigian, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E, Ste 290, Rochester Hills, MI 48307 Phone: 248-997-7900 Fax: 248-997-7918 |